Pharmaceutical Regulatory Affairs

Pharmaceutical Regulatory Affairs, or Pharma Regulatory Affairs, refers to the professionals who maintain regulations from within the assiduity. The pharmaceutical assiduity is the most regulated of all diligence. Regulatory affairs professionals are crucial, but maybe overlooked, players in medicine development. The department of Regulatory Affairs is established to cover public health, by covering and controlling the safety and efficacy of medicines within several disciplines including medicinal, veterinary medicines, agrochemicals, cosmetics, medical devices, fungicides, and reciprocal medicines. The civil controllers are The Office of the Comptroller of the Currency (OCC) The Federal Reserve System.

    Related Conference of Pharmaceutical Regulatory Affairs

    April 24-25, 2025

    18th World Drug Delivery Summit

    London, UK
    May 05-06, 2025

    19th World Drug Delivery Summit

    Vancouver, Canada
    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    June 23-24, 2025

    38th World Congress on Pharmacology

    Paris, France
    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Aix-en-Provence, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands

    Pharmaceutical Regulatory Affairs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in